The Discounted Cash Flow (DCF) valuation of Knight Therapeutics Inc (GUD.TO) is (11.45) CAD. With the latest stock price at 10.01 CAD, the upside of Knight Therapeutics Inc based on DCF is -214.4%.
Based on the latest price of 10.01 CAD and our DCF valuation, Knight Therapeutics Inc (GUD.TO) is a sell. selling GUD.TO stocks now will result in a potential gain of 214.4%.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| WACC / Discount Rate | 5.2% - 7.4% | 6.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (99.22) - (6.44) | (11.45) |
| Upside | -1091.2% - -164.4% | -214.4% |